1. Airway immune responses to COVID-19 vaccination in COPD patients and healthy subjects. Issue 2 (25th August 2022) Authors: Southworth, Thomas; Jackson, Natalie; Singh, Dave Journal: European respiratory journal Issue: Volume 60:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An investigation of the anti‐inflammatory effects and a potential biomarker of PI3Kδ inhibition in COPD T cells. (September 2017) Authors: Khan, Abid; Southworth, Thomas; Worsley, Sally; Sriskantharajah, Srividya; Amour, Augustin; Hessel, Edith M; Singh, Dave Journal: Clinical and experimental pharmacology and physiology Issue: Volume 44:Number 9(2017:Sep.) Page Start: 932 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta Syndrome. (April 2023) Authors: Begg, Malcolm; Amour, Augustin; Jarvis, Emily; Tang, Teresa; Franco, Sara Santos; Want, Andrew; Beerahee, Misba; Fernando, Disala; Karkera, Yakshitha; Sander, Clare; Southworth, Thomas; Singh, Dave; Clark, Jonathan; Nejentsev, Sergey; Okkenhaug, Klaus; Condliffe, Alison; Chandra, Anita; Cahn, Ant... Journal: Pulmonary pharmacology & therapeutics Issue: Volume 79(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Anti-inflammatory effects of the phosphodiesterase type 4 inhibitor CHF6001 on bronchoalveolar lavage lymphocytes from asthma patients. (January 2019) Authors: Southworth, Thomas; Kaur, Manminder; Hodgson, Lynsey; Facchinetti, Fabrizio; Villetti, Gino; Civelli, Maurizio; Singh, Dave Journal: Cytokine Issue: Volume 113(2019) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Anti-inflammatory potential of PI3Kδ and JAK inhibitors in asthma patients. Issue 1 (December 2016) Authors: Southworth, Thomas; Plumb, Jonathan; Gupta, Vandana; Pearson, James; Ramis, Isabel; Lehner, Martin; Miralpeix, Montserrat; Singh, Dave Journal: Respiratory research Issue: Volume 17:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10274 (13th February 2021) Authors: Abaleke, Eugenia; Abbas, Mustafa; Abbasi, Sadia; Abbott, Alfie; Abdelaziz, Ashraf; Abdelbadiee, Sherif; Abdelfattah, Mohamed; Abdul, Basir; Abdul Rasheed, Althaf; Abdul-Kadir, Rezan; Abdulmumeen, Abdulfatahi; Abdulshukkoor, Niyaz; Abdusamad, Kula; Abed El Khaleq, Yazeed; Abedalla, Mai; Abeer Ul A... Journal: Lancet Issue: Volume 397:Issue 10274(2021) Page Start: 605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Issue 10349 (30th July 2022) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Joshua; Abbas, Kasim; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abbott, Alison; Abdallah, Nabeel; Abdelaziz, Ammar; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Audrey; Abdul, Basir; Abdul, Siddiqui; Abdul ... Journal: Lancet Issue: Volume 400:Issue 10349(2022) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Blood eosinophil counts in COPD patients compared to controls. Issue 4 (24th October 2019) Authors: Kolsum, Umme; Southworth, Thomas; Jackson, Natalie; Singh, Dave Journal: European respiratory journal Issue: Volume 54:Issue 4(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10325 (12th February 2022) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abdallah, Nabeel; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Basir; Abdul Rasheed, Althaf; Abdulakeem, Ajibode; Abdul-Kadir, Rezan; Abdullah, Abdullah; Abdulmumeen, Abdu... Journal: Lancet Issue: Volume 399:Issue 10325(2022) Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease. (May 2015) Authors: Gupta, Vandana; Banyard, Antonia; Mullan, Aoibheann; Sriskantharajah, Srividya; Southworth, Thomas; Singh, Dave Journal: British journal of clinical pharmacology Issue: Volume 79:Number 5(2015:May) Page Start: 767 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗